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The visualization of molecularly labeled structures
within large intact tissues in three dimensions is an
area of intense focus. We describe a simple, rapid,
and inexpensive method, iDISCO, that permits
whole-mount immunolabeling with volume imaging
of large cleared samples ranging from perinatal
mouse embryos to adult organs, such as brains or
kidneys. iDISCO is modeled on classical histology
techniques, facilitating translation of section staining
assays to intact tissues, as evidenced by compati-
bility with 28 antibodies to both endogenous anti-
gens and transgenic reporters like GFP. When
applied to degenerating neurons, iDISCO revealed
unexpected variability in number of apoptotic neu-
rons within individual sensory ganglia despite tight
control of total number in all ganglia. It also permitted
imaging of single degenerating axons in adult brain
and the first visualization of cleavedCaspase-3 in de-
generating embryonic sensory axons in vivo, even
single axons. iDISCO enables facile volume imaging
of immunolabeled structures in complex tissues.
INTRODUCTION
Immunolabeling is a central technique in many areas of biolog-
ical research and medical diagnosis, making it possible to reveal
the morphology and molecular composition of biological sam-
ples. However, its application has been mostly restricted to
thin preparations or small samples owing to the difficulty of label-
ing and observing deep structures in intact specimens. 3D imag-
ing is particularly valuable when analyzing complex structures
that are not contained within 2D planes, such as axonal tracts
or the vasculature. Moreover, volume data sets allow more flex-
ibility for analysis than tissue sections for quantitative studies of
cell number counts or relative distance measurements.
It has been recognized for a century that biological speci-
mens can be made optically transparent by methods that896 Cell 159, 896–910, November 6, 2014 ª2014 Elsevier Inc.reduce internal differences in refractive index within the tissue
to reduce scatter, thus enabling visualization of deep structures
(Spalteholz, 1914). Recently, there has been a resurgence of in-
terest in optimizing methods for volume imaging of molecularly
labeled structures in large, cleared tissue samples, leading to
the development of several important new clearing methods:
ScaleA2 (Hama et al., 2011), 3DISCO (Ertu¨rk et al., 2012a,
2012b, 2014), ClearT2 (Kuwajima et al., 2013), SeeDB (Ke
et al., 2013), CLARITY (Chung et al., 2013; Tomer et al.,
2014; Yang et al., 2014), and CUBIC (Susaki et al., 2014). These
methods were mostly developed with an eye to preserving
endogenous fluorescence of proteins such as GFP, YFP and
mCherry expressed from transgenes. However, the steps
used to achieve this in some cases constrain their versatility
for rapid and robust immunolabeling. Several use aqueous so-
lutions to preserve fluorescence, but this makes optical
clearing slow for large tissues (2–6 weeks) and can hinder
transparency for subsequent imaging; as well, some use highly
denaturing agents (e.g., urea or SDS), to which some epitopes
recognized by antibodies of interest may be sensitive, and
some are difficult to implement and/or to scale (Table S1 avail-
able online).
In this study, we focused on establishing a simple, rapid,
robust, scalable, and inexpensive method for whole-mount im-
munolabeling of deep tissue structures with volume imaging.
We deemed the preservation of endogenous fluorescence of
proteins like GFP to be valuable but not absolutely essential,
because visualization of such proteins can also be achieved
independently by immunolabeling them. We first systematically
tested and modified existing whole-mount immunolabeling
methods to achieve the best signal-to-noise ratio and deepest
tissue penetration in a reasonable time frame in tissues ranging
from largemouse embryos to adult mouse brains and other com-
plex organs. We also evaluated the recently published clearing
methods for their ability to support robust and rapid immunolab-
eling of a range of antigens. Table S1 lists strengths and limita-
tions of eachmethod for that purpose, as assessed in our hands.
That analysis led us to focus on 3DISCO (3D imaging of solvent-
cleared organs) (Ertu¨rk et al., 2012a) because it is rapid, simple,
and provides excellent clearing that is compatible with immuno-
labeling (Table S1).
Through this comprehensive analysis, we found that several
modificationsof existingwhole-mount immunolabelingmethods,
when combined with 3DISCO clearing, create a platform that
provides robust and reliable labeling of deep structures not just
in large embryonic but also in dense adult tissues. We term this
method immunolabeling-enabled three-dimensional imaging
of solvent-cleared organs (iDISCO). Its strengths include the
following.
d It enables deep antibody diffusion in tissues in whole
embryos, even those as large as embryonic day 18.5
(E18.5), as well as in dense complex adult organs,
including the brain and kidney.
d It is designed to be simple to implement and was modeled
after traditional histology techniques, so all reagents for
sample processing are common and inexpensive, and no
special lab equipment is required.
d It has a relatively fast turnover because 3DISCO clearing
takes only a day, compared to weeks for other methods
with similar clearing performance (Table S1). Thus,multiple
rounds of sequential analysis can be done in a reasonable
time frame, as samples can be harvested, immunolabeled
and cleared in 8–18 days depending on size (Table S2).
d Whereas some other clearing platforms cause samples to
be unstable in the index matching solution, necessitating
prompt imaging and storage in a different solution, iDISCO
uses Alexa Fluor dyes, which can be imaged repeatedly
with very low photobleaching and are stable for many
months in the index matching solution at room tempera-
ture. The immunolabeling patterns are also fixed in the
sample, with no diffusion over time.
d It is compatible with labeling methods relying on click-
chemistry, as well as with some but not all histochemical
dyes (e.g., dyes of the TO-PRO family of nuclear DNA
stains).
d Importantly, if an antibody provides a good signal and low
background when used in immunohistochemistry (IHC) on
tissues sections, our experience indicates it has a good
chance of working with iDISCO. Indeed, we tested 28
antibodies that work well in IHC and all worked success-
fully with iDISCO (Table S3).
Together with light-sheet microscopy (Dodt et al., 2007), these
features make iDISCO a versatile, reliable, and consistent ana-
lytic platform and one that is easy to scale to large numbers of
samples, potentially in the hundreds.We illustrate the application
of themethod to detect a variety of antigens (some sparse, some
widely expressed) in numerous embryonic and adult neural and
nonneural structures (including kidney, muscle, stomach, and
the vasculature), to visualize proliferating cells and axonal projec-
tions, to visualize a reporter of neuronal activity (c-fos), and to
address some outstanding questions in neural degeneration.RESULTS
Whole-Mount Immunolabeling of Large Samples
Various whole-mount immunolabeling protocols have been
developed to visualize marker expression in small specimenssuch as young mouse embryos (generally up to E12.5),
Drosophila larvae and brains, or mammalian—including hu-
man—brain slices up to 1 mm in thickness. We tested and com-
bined some of these approaches, including the use of nonionic
detergents and rounds of organic solvent-based dehydration-
rehydration to remove membrane lipids for permeabilization of
larger samples, as well as bleaching with hydrogen peroxide to
reduce tissue autofluorescence. We found that combining
glycine and heparin treatment to reduce immunolabeling back-
ground gave excellent results for whole mouse embryos up to
stage E18.5, as well as whole adult mouse brains, kidneys, and
other organs. The use of methanol for tissue bleaching improved
immunolabeling for most antibodies we tested (25 of 28) but also
prevented antigen recognition by a few (3 of 28) (see below). To
broaden the spectrum of applications, we developed two alter-
nate immunolabeling protocols, one with nondenaturing condi-
tions and the other involving mild denaturation with methanol.
For each antibody tested, we assessed which protocol to use
by comparing signal-to-noise ratios (Table S3). When compat-
ible, we recommend using methanol treatment, especially in
adult tissues, to maximally reduce tissue autofluorescence and
improve antibody diffusion; the nondenaturing approach pro-
vides an alternative if needed that can still give excellent results
in embryos and trimmed adult tissues.
Because tissue autofluorescence of large biological samples
is strong in the blue-green spectrum, fluorophores in the red
spectrum help reduce background and ones in the far-red spec-
trum are even better (see comparison in Figure S1). In this study,
we use Alexa Fluor-647 (far-red spectrum) for most stainings
shown. Exceptions are Alexa Fluor-488 for TrkA colabeling in
Figure 6B, Alexa Fluor-568 for Aquaporin 2 colabeling in Fig-
ure 4A, TrkA colabeling in Figure 4C, E16.5 forearm TrkA labeling
in Figure 2C, and cCasp3 labeling in Figure 6.
Finally, after immunolabeling the ideal clearing protocol should
not only provide excellent clearing, but also be rapid, easy to
implement, inexpensive, and compatible with a broad range of
antigens. In assessing clearing methods according to these
five criteria, we found 3DISCO to be the best for our purposes
(Table S1). 3DISCO was developed as an improvement over
the classical benzyl alcohol-benzyl benzoate (BABB) method
to enable clearing of lipid-rich tissues such as myelinated tracts
in the adult nervous system and was initially used to visualize
vasculature labeled with a fluorescent lectin and GFP-labeled
axons (Ertu¨rk et al., 2012a, 2012b). In our hands, it provides
clearing that is as good or better than that of other methods
we tested, and it is also extremely rapid (1 day), inexpensive,
and very easy to implement (Table S1). One limitation is that
the organic solvent it uses rapidly quenches endogenously fluo-
rescent proteins, necessitating prompt imaging if the purpose is
to visualize such signals (Ertu¨rk et al., 2014; Ke et al., 2013).
However, while not initially combined with immunolabeling, the
methods are fully compatible (Ertu¨rk et al., 2014; A. Che´dotal,
personal communication; our observations), and, importantly,
Alexa Fluor dyes are very stable at room temperature in the
organic solvents it uses.
The iDISCO protocol combines the steps of sample prepara-
tion and immunolabeling with stable fluorophores outlined
above, together with a slightly simplified 3DISCO procedure, toCell 159, 896–910, November 6, 2014 ª2014 Elsevier Inc. 897
permit volume imaging of labeled molecules and structures in
large intact samples. It is detailed in Data S2.
Application of iDISCO
We first illustrate the utility of iDISCO using FoxP2 immunolabel-
ing on adult (4 months old) mouse brain, as this transcription fac-
tor, well-studied for its role in the specification of neural networks
involved in vocalization (Enard et al., 2009), is widely expressed
throughout the brain (Ferland et al., 2003; Fujita and Sugihara,
2012). For processing, the brainstem and cerebellum were left
intact, but the forebrain was cut in two to reduce the time
required for good clearing and antibody diffusion. After immuno-
labeling and clearing, the brain was imaged on a light-sheet
microscope.
In the brainstem, we detected FoxP2 expression in the inferior
olive (IO) (see Table S4 for a list of all anatomical abbreviations
used here) in a pattern that perfectly matches that observed in
cryosections made at the same level (Figure 1A; Movie S1) and
in previous studies (Fujita and Sugihara, 2012). Consistent with
a previous report (Horng et al., 2009), FoxP2-positive cells
were also detected throughout the whole forebrain, notably in
the striatum, the sixth cortical layer, and the thalamic medial
geniculate nucleus (MGN), thus showing that the deepest struc-
tures (more than 2mmdeep) could be labeled in patterns match-
ing known FoxP2 expression (Figure 1A). The signal-to-noise
ratio and resolution were sufficiently high to enable automated
counting of the total number of FoxP2 positive cells in the IO
using Imaris software. In the sample shown, 26,839 cells were
counted, consistent with numbers previously estimated from tis-
sue sections, i.e., between 24,000 and 30,000, depending on
mouse strain (Frederic et al., 1992).
Application to Axonal Projections
Visualizing axon tracts is another important application for vol-
ume imaging. We used an antibody against tyrosine hydroxylase
(TH) to label dopaminergic neurons and their projections in E15.5
embryos and adult brains (Figure 1B). iDISCOmade it possible to
label the entire embryonic head without dissecting out the brain,
making the TH-positive peripheral sensory axons in the head
also visible (Figure 1B; Movie S1). Using software, we could
also perform a ‘‘virtual’’ dissection of the brain to examine axons
just within the brain, without surrounding tissues in the head (Fig-
ure 1B; Movie S1). In this preparation, it was possible to follow
the mesotelencephalic pathway (MTp) from the midbrain nuclei
to the developing forebrain. In P0 whole brain and in adult
midbrain, individual neurons of the substantia nigra (SN) and
ventral tegmental area (VTA), as well as their projections, can
be visualized (Figure 1B).
We also visualized axons of sensory neurons with cell bodies
located in the dorsal root ganglia (DRGs). These neurons send
axons to both the CNS and the periphery. Each DRG contains
several subtypes of sensory neurons specialized for different
kinds of inputs. The expression of the neurotrophin receptors
TrkA, TrkB, TrkC, and Ret can be used to label distinct subpop-
ulations. TrkA labels mostly nociceptive inputs, whereas TrkB,
TrkC, Ret, and tyrosine hydroxylase label different kinds of low
threshold mechanosensory receptor (LTMR) neurons (Abraira
and Ginty, 2013). We visualized each of these subpopulations898 Cell 159, 896–910, November 6, 2014 ª2014 Elsevier Inc.in whole embryos at E12.5 (Figure 2A). TrkA, TrkC, and tyrosine
hydroxylase antibodies exclusively labeled neuronal structures,
whereas TrkB and Ret additionally labeled nonneural structures.
An antibody to parvalbumin also successfully labeled a subset of
DRG neurons (Table S3 and data not shown). TrkA-labeled em-
bryos from E12.5 to E16.5 could be rapidly imaged whole at high
resolution (heads were removed for E16.5 embryos) (Figure 2B;
Movie S2). We clearly and reproducibly labeled both major and
minor nerve branches and observed fine details in regions
such as thewhisker pad, tongue, and entire forelimbs (Figure 2C),
as well as the fibers innervating the skin (Figure 2D). Tuj1, which
labels all axons, showed denser labeling in the same region
(Figure 2C).
Application to Visualizing Transgenic Reporters
While antibodies that work well on histological sections are
readily compatible with iDISCO, many structures cannot be
specifically labeled with available antibodies to endogenous mo-
lecular markers. However, widely available transgenic mouse
collections are a valuable resource for neuroanatomical
studies of specific structures. We set out to apply iDISCO in a
classic reporter line paradigm by using the ChAT::cre ;
Rosa26lox-stop-lox-tdTomato floxed reporter line, in which a fluores-
cent reporter (tdTomato) is expressed under the control of the
choline acetyl transferase (ChAT) promoter, to visualize cholin-
ergic neurons and their projections. We labeled a young adult
(1 month old) mouse forebrain cut sagittally in half. In this prep-
aration, we could visualize the motor nuclei of the Vth and IIIrd
cranial nerves, the fasciculus retroflexus, and many cholinergic
interneurons in the cortex and the striatum (Figure 3A; Movie
S3). We also verified that the procedure enables a high-resolu-
tion view of the neurites of the cholinergic interneurons. It was
possible to image and reconstruct individual neurons because
of the sparse expression of the ChAT::cre in the cortex and stria-
tum (Figure 3A; Movie S3).
Various Thy1::GFP lines were developed as a modern alterna-
tive to Golgi staining to label excitatory projection neurons (Feng
et al., 2000). Using an Abcam anti-GFP antibody (Table S3), we
tested iDISCO on the Thy1::GFP-M line, which has the most
sparse GFP expression of all reported Thy1 lines (Feng et al.,
2000). As shown in Figure 3B and Movie S3, this sparse expres-
sion simultaneously enables imaging of the entire pattern
throughout the brain (at lower magnification) together with reso-
lution of individual axons (at high magnification). We also tested
two additional GFP antibodies, one fromAves that also gave very
good results with the methanol treatment protocol, and another
from Invitrogen that worked only in nonmethanol-treated sam-
ples (and that is therefore not recommended) (Table S3 and
data not shown).
Epitope tags such as LacZ, HA, and myc are also commonly
used.We expect themethod to work with any tag for which there
is a good antibody that works well in IHC on sections. As an
example, we tested the compatibility of iDISCO with the LacZ
tag in a Netrin-1 gene-trap line in which a b-galactosidase fusion
is driven from the Netrin-1 locus (Serafini et al., 1996). Using an
antibody to b-galactosidase, high level expression was observed
at the midline in the spinal cord and caudal brain as expected
(Serafini et al., 1996), and lower levels could be observed in
Figure 1. Whole-Mount Immunolabeling of Adult Brain and Entire Embryonic Head
(A) FoxP2 immunolabeling of a 4-month-old mouse brain. The coronal 35 mm cryosection immunolabeled for FoxP2 at the level of the Inferior Olive, and the
matching coronal optical plane (1.6mmdeep in the tissue) from awhole-mount-labeled caudal adult brain (cerebellum and hindbrain). Right: sagittal projection of
an adult half-forebrain, showing FoxP2 labeling in the cortex, olfactory bulb, striatum, and thalamus. The brain was scanned in coronal orientation from both
rostral and caudal ends. The scans met in the middle of the sample. Optical sections at the indicated levels from the same brain are shown below.
(B) Top tyrosine hydroxylase (TH) labeling of an E15.5mouse embryo head showing optical sections through themidbrain and thalamus, and virtual dissections of
the brain (bottom). Bottom: optical section of an adult (8 weeks old) mouse midbrain showing dopaminergic neurons of the midbrain. Anatomical abbreviations
are listed in Table S4. Scale bars represent 500 mm.
See also Figure S3, Tables S1, S2, S3, and S4, and Movie S1.
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skin and various organs such as tongue, limbs, and heart (Fig-
ure 3C; Movie S3).
Application to Nonneuronal Tissues and Use of Widely
Expressed Markers
We tested iDISCO on whole adult mouse kidneys, which are
approximately the size of E14.5 mouse embryos. We could visu-
alize and count all glomeruli in intact kidney by immunolabeling
for nephrin (Figure 4A; Movie S4). To visualize the collecting
ducts, we immunolabeled for Aquaporin 2 (Figure 4A; Movie
S4). We noticed in initial experiments that the Aquaporin 2 anti-
bodies did not penetrate the center of the sample. We reasoned
that thismight be due to the very high abundance of the protein in
kidney, which could result in most IgG molecules being ad-
sorbed on the superficial ducts. After estimating the coverage
in the first attempts (20%), we increased the concentration of
the antibody 10-fold (from 1/200 to 1/20 dilution) and success-
fully labeled all collecting ducts in a whole kidney (see Figure S2).
General nuclear stains are a valuable tool to quickly label tis-
sues and reveal their ultrastructure. We screened for nuclear
DNA stains that could be compatible with iDISCO. Although
Draq5 and Hoechst were not compatible, we found that
cyanine-based dyes of the TO-PRO family of nuclear DNA stains
worked well, which we used as a counterstain for Aquaporin 2 in
adult kidney (Figure 4A; Movie S4). It should be noted that to be
useful in resolving individual cells, general nuclear stains require
high resolution imaging (Figure S3), which was beyond the reso-
lution of the light-sheet microscope available to us and achieved
here using confocal microscopy. We designed a 3D-printed
imaging chamber to enable the use of confocal and two-photon
microscopes (Figure S4; Data S1).
Imaging at higher resolution with confocal and/or two-photon
microscopy also enabled us to use two widely expressed gen-
eral markers, E-cadherin and b-catenin, to help identify different
types of kidney tubules (Reginensi et al., 2013) (Figure 4A; Movie
S4). Anti-laminin was also useful for that purpose, and because
of its sparser labeling, could be imaged effectively with our
light-sheet microscope (Movie S4). We also found that general
markers of the extracellular matrix can also be used to visualize
cellular architecture in other organs, includingmuscle (Figure 4B;
Movie S4) and stomach (Movie S4).
To visualize vasculature, we used an antibody against PeCAM
to immunolabel blood vessels, in combination with TrkA for sen-
sory axons in E14.5 embryos (Figure 4C; Movie S4). As for
Aquaporin 2, PeCAM-labeling required a high antibody concen-
tration to achieve full coverage. The CNS as well as internal
organs such as the heart (Figure 4C), kidney, and intestines,
were well labeled. Although axons and vessels are well knownFigure 2. Whole-Mount Imaging of the Embryonic Peripheral Sensory
(A) E12.5 embryos labeled for TrkA, TrkB, TrkC, and ret, and E15 embryo label
thoracic (TrkA and TrkB), lumbar (TrkC), or cervical (ret and TH) DRGs.
(B) Half projections of whole embryos labeled for TrkA.
(C) Details of the TrkA innervation at E14.5 in the whisker pad, tongue, and thorac
with TrkA and imaged with a two-photon microscope.
(D) Partial projections of the flank region in E14.5 and E16.5 whole embryos labeled
S4. Scale bars represent 500 mm.
See also Figures S1, S3, and S4, Tables S1, S2, S3, and S4, and Movie S2.to be aligned in many tissues, in the face colabeling of the vascu-
lature and main axonal tracts did not reveal a perfect overlap,
especially in the case of the major branches of both systems
(Figure 4C), consistent with a recent report (Oh and Gu, 2013).
Application to Cell Proliferation, Click Chemistry, and
Phosphorylated Epitopes
Cell proliferation in developing or adult tissues can be visualized
with a pulse of a synthetic nuclei acid like BrdU or EdU, which is
detected using click chemistry. We tested the compatibility of
EdU and the click chemistry reactions with iDISCO by giving a
pulse of EdU to a pregnant dam at day 14 of gestation and har-
vesting embryos 1 hr later. Embryos were processed with the
iDISCO protocol, and the click reaction was performed as
directed. EdU incorporation could be visualized as expected in
skin and proliferative regions after clearing (Figure 5A; Movie
S5). In the brain, EdU incorporation was seen in the neurogenic
regions, such as the subventricular zone, the third ventricle,
the midbrain, the cerebellum, and the rhombic lips in the
hindbrain.
Phosphohistone H3 (pHH3) is another commonly used marker
to study cell proliferation. The labeling is sparse compared to
EdU as pHH3 only labels cells in metaphase. We labeled intact
E14 embryos with pHH3. Because of the sparse labeling, we
could discriminate individual dividing cells in various brain re-
gions at low magnification (Figure 5B; Movie S5). Virtual dissec-
tion of the lateral ventricle enabled a complete view of all dividing
cells in the telencephalon (Movie S5).
Many other phosphorylated epitopes are also of interest for a
variety of applications. We tested antibodies to two distinct
phosphorylated epitopes on cJun for their ability to detect
cJun phosphorylation in DRG sensory neurons triggered by
sciatic nerve transection, and both worked well (Table S3 and
data not shown).
Application to Neuronal Activity
Recent neuronal activity can be probed postmortem by the
neuronal expression of immediate early genes (IEGs) (Goelet
et al., 1986). Among the IEGs, c-fos expression has been shown
to label recently active neurons in many systems where its
expression is usually triggered about 30 min after a stimulus. In
the spinal cord, c-fos expression can be induced in dorsal horn
interneurons after a painful stimulus of the hind paw (Hunt
et al., 1987).We tested the compatibility of c-fos immunolabeling
with iDISCO in lumbar spinal cord. The left hind paws of anesthe-
tized adult mice were dipped in a 52C water bath and the mice
were left to recover for 2 hr. C-fos immunolabeling was observed
in 3D unilaterally in the left dorsal horn at the levels of the roots ofNervous System
ed for tyrosine hydroxylase. Sagittal maximum projections at the level of the
ic DRGs, and Tuj1-labeled innervation in the flank skin. E16.5 forearm labeled
for TrkA showing skin innervation. Anatomical abbreviations are listed in Table
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Figure 3. Whole-Mount Immunolabeling of
Transgenic Reporter Lines
(A) Projection of a whole-mount RFP immunolab-
eling of a 1-month-old mouse half forebrain from
a ChAT::cre ; Rosa26lsl-tdTomato reporter line,
showing details of the midbrain, cortex and optical
sections at different levels.
(B) Whole-mount GFP immunolabeling of a
1-month-old mouse half forebrain from a
Thy1::GFPm line. Insets: details of the hippo-
campus, striatum, and cortical pyramidal neurons.
(C)Whole-mount b-galactosidase immunolabeling
of an E14 Netrin-1lacZ/+ embryo. Sagittal optical
section at the level of the spinal cord and trans-
verse optical sections at the levels of the spinal
cord, hindbrain, and thalamus. Anatomical ab-
breviations are listed in Table S4. Scale bars
represent 500 mm.
See also Figure S3, Tables S1, S2, S3, and S4, and
Movie S3.the L4 and L5 DRGs (Figure 5C; Movie S6). We also observed
deeper c-fos-positive interneurons and motoneurons, showing
that antibody penetration was not limited to the superficial layers
in this heavily myelinated tissue.
Application to Apoptosis and Neurodegeneration
Naturally occurring apoptotic cell death during development is
critical for determining the final number of sensory neurons in
adult DRGs (Deckwerth et al., 1996; Sun et al., 2003; White
et al., 1998). This process can be studied using antibodies
that recognize a neo-epitope within Caspase-3 (Casp3) that re-902 Cell 159, 896–910, November 6, 2014 ª2014 Elsevier Inc.sults from proteolytic cleavage by up-
stream caspases. Using iDISCO, we
visualized cCasp3 in many DRG neuron
cell bodies (Figure 6A); labeling was spe-
cific, as it was completely abolished in
embryos lacking Casp3. It was also
largely abolished in sensory neurons in
mice mutant for Bax, which is upstream
of Casp3, but was still present in non-
neuronal cells, consistent with a known
redundancy of Bax and its relative Bak
in some tissues (Lindsten et al., 2000).
Interestingly, a few cCasp3 positive neu-
rons remained in some DRGs in Bax/
embryos, suggesting redundancy with
Bak in subsets of sensory neurons as
well (Middleton and Davies, 2001). We
also visualized cleaved Caspase 9
(cCasp9) with iDISCO in subsets of sen-
sory neurons, although the antibody only
worked without methanol pretreatment
and yielded a weaker signal (Table S3
and data not shown).
Genetic and other evidence implies
that Casp3 is also required within sensory
axons for degeneration in vitro and axonpruning in vivo (Simon et al., 2012), but detection of cCasp3 in
axons in vivo during normal development has remained elusive.
Using a more sensitive antibody to cCasp3 (Table S3) in combi-
nation with iDISCO, we were able to document for the first time
the presence of cCasp3 in sensory axons from the DRG and tri-
geminal ganglion during developmental degeneration in vivo
(Figure 6B). In Bax/ embryos, where cCasp3+ neurons are
rare (see above), staining was sufficiently sparse that cCasp3
could be observed with single axon resolution (Figure 6A, inset).
Interestingly, we did not observe enrichment of cCasp3 at axonal
branch points, which is different from what has been reported
Figure 4. Application to Adult Kidney and Muscle and Embryonic Vasculature
(A) Upper row: Aquaporin2 labeling in adult mouse half-kidneys (labeling collecting ducts), and Nephrin in mouse whole kidneys (labeling glomeruli). Lower row:
higher magnification optical sections of Aquaporin2 colabeled with TO-PRO-3, E-cadherin, and b-catenin in adult kidneys.
(B) Laminin whole-mount immunolabeling of the vastus (hindlimb muscle) of an adult mouse.
(C) PeCAM labeling in an E14.5 whole embryo. Partial projection of the chest region showing the heart, and detailed views of the whisker pad colabeled with TrkA.
Anatomical abbreviations are listed in Table S4. Scale bars represent 500 mm, except (A) lower row: 100 mm.
See also Figures S2, S3, and S4, Tables S1, S2, S3, S4, and Movie S4.
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Figure 5. Application to Cell Proliferation and Neuronal Activity
(A) Whole-mount phosphohistone H3 immunolabeling of an E14 embryo, with details of mitotic cells in the midbrain (1), thalamus (2), or cortical ventricular
zone (3).
(B) E14.5 embryo treated for 1 hr with an EdU pulse before fixation, showing proliferating cells in the skin and in diverse brain regions, such as the rhombic lips
(arrowhead), cerebellum, and midbrain (2) and cortical ventricular zone (3).
(C) c-fos expression in the lumbar region of the spinal cord in an adult mouse after a heat stimulation of the hind paw. 3D view of the spinal cord, projection of
horizontal planes, and optical section in the coronal plane. c-fos expression is seen on the side ipsilateral to the stimulation in the dorsal horn interneurons.
Anatomical abbreviations are listed in Table S4. Scale bars represent 500 mm.
See also Tables S1, S2, S3, and S4 and Movies S5 and S6.with a caspase activity reporter in zebrafish retinal ganglion cell
axons (Campbell and Okamoto, 2013). Our results support the
model that local activation of Casp3 is important for develop-
mental pruning of sensory axons.
An important application of volume imaging is to count the ab-
solute number of objects more easily than from tissue sections.
We quantified the number of cCasp3 positive cells in each DRG
in embryos ranging from E12.5 to E16.5 (Figure 6C). We
confirmed that the number of apoptotic cells peaks at E14.5
(White et al., 1998) and found that apoptotic cells were present
between E11.5 and E16.5, a larger range than previously appre-
ciated. No cCasp3 positive cells were observed at E10.5 (data
not shown). Interestingly, we found significant variability in the
number of apoptotic cells between left and right ganglia from904 Cell 159, 896–910, November 6, 2014 ª2014 Elsevier Inc.the same spinal cord segment, but when the total number of
apoptotic cells in ganglia were integrated over spinal cord
segments that innervate a shared target (e.g., cervical DRGs
[C5–C8] subserving the forelimbs) or over the entire embryo
(C2–S1), the numbers of apoptotic cells were strikingly similar
between sides (Figures 6D and S5). This apparent homeostasis
fits with the model that neuronal numbers are set by competition
for limiting amounts of target-derived trophic factor, such that
neurons within any given DRGs might capture more (or less) of
the target-derived factor(s) but the total number subserving a
particular target would be fixed by target size.
Retinal ganglion cells (RGCs) projections from the retina to the
dorsolateral geniculate nucleus (dLGN) or superior colliculus
(SC) provide another commonly used system for studying axon
targeting and pruning in vivo. They can be efficiently anterog-
radely labeled by intravitreous injection of cholera toxin beta
(CTb) conjugated to Alexa Fluor 594 or 488 (Muir-Robinson
et al., 2002). We used 3DISCO to clear an adult mouse brain after
bilateral injection of CTb-A594 and CTb-A488. On the light-sheet
microscope, it was possible to scan through the dLGN and
observe ipsilateral and contralateral territories at high resolution
(Figure 7A). Whereas classical tissue sections may provide
higher resolution image for any given 2D plane, the advantage
of volume imaging is to make it possible to investigate the entire
projections in different orientations using a single sample.
One limitation of bulk CTb injections is the difficulty of
resolving single axons and their terminals because of massive
labeling. To observe single RGC axon projections with high res-
olution in adult brain using iDISCO, we sparsely labeled axons
from RGCs with intravitreous injection of an adeno-associated
virus (AAV2) driving expression of tdTomato. We immunolabeled
the entire brain (cortex removed) using an antibody to RFP.
Single axons labeled throughout the whole brain could be
visualized from the optic nerve to the dLGN and SC (Figure 7B).
To study neurodegeneration, we performed optic nerve crush
injuries and observed degeneration of single axons in the brain.
The transparency of the tissue was such that degenerated
axons in the optic chiasm could be imaged from the dorsal
side of the brain, through the entire tissue (Figure 7B). This
method allows for a simple and rapid assessment of axon
degeneration and regeneration in various regions of the central
nervous system following different neural insults or under patho-
logical conditions.
DISCUSSION
We have leveraged the 3DISCO clearing protocol to devise a
rapid and simple yet powerful method, iDISCO, for whole-mount
immunolabeling and 3D visualization of molecular markers in
large, complex, intact embryonic, and adult tissues. The detailed
iDISCOprotocol can be found in the Extended Experimental Pro-
cedures and as a bench protocol available online (Data S2).Our
experience is that for any given antibody, the quality of immuno-
labeling observed on tissue sections predicts the quality that will
be observed with whole-mount immunolabeling using iDISCO,
making the method very versatile. A number of important exper-
imental considerations warrant discussion.
Choice of Tissue Clearing Protocol
Many clearing protocols have recently been published. They
represent a valuable toolbox to address different questions,
which may be best answered with different protocols. iDISCO
is particularly powerful for immunolabeling applications.
CLARITY or CUBIC may be better if the desired application is
to image endogenous fluorescence of reporters such as GFP
or tdTomato, which is quenched within 7–8 hours by the 3DISCO
clearing procedure (Ertu¨rk et al., 2014; Ke et al., 2013). In prac-
tice, however, this is not a serious limitation for iDISCO, because
such reporters can also be visualized by immunolabeling them.
In fact, it can often be more advantageous to visualize them by
immunolabeling, as their endogenous fluorescence can fade
during prolonged imaging and storage of archived samples,whereas the Alexa Fluor dyes used in iDISCO are highly resistant
to bleaching and stable in long-term storage at room tempera-
ture. As well, because of tissue autofluorescence in the blue-
green spectrum (Figure S1), imaging of fluorescence from the
most common reporters like GFP (that emit in that spectrum) is
de facto limited to transgenic lines with high expression—the
only examples reported so far in the literature. In contrast, with
immunolabeling the signal from the transgenic reporter can be
boosted and shifted to the far-red region of the spectrum to
avoid tissue autofluorescence, enabling detection of moderately
expressed reporters in addition to endogenous antigens.
One limitation of iDISCO is that it is currently incompatible with
the original Brainbow and Confetti mice (Livet et al., 2007; Snip-
pert et al., 2010), which provide a rich spectral repertoire of fluo-
rescent signals from multiple fluorescent proteins expressed
simultaneously, because antibodies that distinguish those pro-
teins are not available. However, the newer version 3 Brainbow
lines have been designed to support immunostaining by use of
non-cross-reacting antibodies to individual fluorescent proteins
(Cai et al., 2013) and thus could be compatible with iDISCO.
Selection of Antibodies
All 28 antibodies used in this study gave good results with
iDISCO (Table S3), but it should be noted that the antibodies
were carefully prescreened. We first tested antibodies on sec-
tions pretreated with methanol to mimic the effect of methanol
in the iDISCO protocol. Twenty-five of the antibodies gave
good results in that test (Table S3) and all performed very
well in iDISCO usingmethanol pretreatment (i.e., with similar sig-
nal-to-noise ratios as on sections). For the three antibodies
whose epitopes were sensitive to methanol pretreatment (anti-
PECAM, anti-cCasp9, and one of the anti-GFP antibodies; Table
S3), iDISCO was performed with the no-methanol version of the
protocol, which also gives good results (see Figure 4C for anti-
PECAM staining) but can require longer incubation times and
yield greater tissue autofluorescence (see below). Note also
that the primary antibodies used here were all made in rabbits,
goats, rats, or chickens (Table S3). We specifically avoided anti-
bodies made in mice, as they often give high background on
mouse tissues when detected with anti-mouse secondary anti-
bodies. In line with that expectation, a pilot experiment with a
mouse monoclonal antibody to Calbindin (Swant; no. 300) on
adult brain yielded less satisfactory results (i.e., although there
was a strong signal, there was also high background; data not
shown). Further studies are required to determine whether the
background is due to use of anti-mouse secondary antibody,
and whether any background that is observed can be reduced
by modifying the protocol.
Antibody Penetration
We achieved complete antibody diffusion in samples that are
large enough that they are representative of most mouse sam-
ples of interest. We tested intact mouse embryos for stages up
to E18, and found good penetration at all stages, and we verified
that antibodies can label the center of intact adult mouse brains
(undissected) with just 4 days of primary antibody incubation
at 37C. Nonetheless, to maximize antibody penetration in a
reasonable time frame and to permit use of lower primary anti-
body concentrations, we recommend dissecting organs ofCell 159, 896–910, November 6, 2014 ª2014 Elsevier Inc. 905
(legend on next page)
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Figure 7. Study of Neurodegeneration with iDISCO
(A) Tracing of the visual projections in a 3-week-old mouse by cholera toxin beta (CTb) injection in the eye. Ipsilateral projections pseudocolored in green,
contralateral in red. Coronal vibratome section (100 mm) at the level of the dLGN nucleus (left panel) compared to a horizontal optical section and reconstructions
in the coronal plane or in a 3D lateral view (right three panels).
(B) Adult wild-type mouse brain (cortices removed) labeled for tdTomato after a bilateral viral delivery of AAV2::tdTomato in the retina. The optic nerve was
crushed unilaterally and the brain harvested after 0 or 6 days. Axon fragmentation can be seen 6 days after the nerve crush in the visual tracts and at the axons
terminals in the superior colliculus. Anatomical abbreviations are listed in Table S4. Scale bars represent 500 mm except optic tracts (100 mm).
See also Tables S1, S2, S3, and S4.interest from embryos older than E16, and in general we recom-
mend trimming samples to a size relevant to the biological ques-
tion. For example, in the case of adult brain, when compatibleFigure 6. Analysis of cCasp3 in Sensory Neurons and Their Axons
(A) Whole mount labeling of E14.5 wild-type, Caspase3/, and Bax/ embryos
much reduced levels in Bax/ embryos and not at all in Caspase3/ embryos
(arrows).
(B) High-magnification view of the lumbar region and whisker pad, showing cC
Caspase3/ embryos. Axonal cCasp3 is not detected in Caspase3/ embryos
(C) Whole mount E12.5, E13.5, E14.5, and E16.5 embryos labeled for cCasp3. The
the Bax/ at E14.
(D) View of the left and right sides of the same embryo at E12.5, and comparison
between cognate DRGs from the two sides, the overall sum remains the same for D
in Table S4. Scale bars represent 500 mm (A), 100 mm (B) and 200 mm (C and D).
See also Figure S5 and Tables S1, S2, S3, and S4.with the study aims we have cut the forebrain in half sagittally
or removed one or both cortices to achieve faster diffusion times
and to maximize image quality.for cCasp3. cCasp3 is abundantly detected in wild-type DRG neurons, but in
. Inset in the Bax/ embryo shows individual cCasp3+ axons within a DRG
asp3 staining in sensory axons (double-labeled with TrkA) in wild-type and
.
number of cCasp3+ cells peaks at E14.5. The number is drastically reduced in
of cCasp3 counts on both sides. Although the numbers of cCasp3 can change
RGs projecting to the same target regions. Anatomical abbreviations are listed
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Antibody concentration is an important factor that must be
optimized to achieve good labeling. Our results indicate that
antibody availability is not limiting for sparsely or moderately ex-
pressed proteins, such as transcription factors, subclass-spe-
cific markers, or reporter genes. For such antigens—the majority
of those tested here—the very same antibody concentration
used for IHC on tissue sections can also be used in the iDISCO
procedure (Table S3). However, we also found that bioavailability
of antibodies against proteins that are highly abundant and
widely expressed, such as PeCAM, acetylated tubulin, or Aqua-
porin 2, can be more limited, presumably because of titration of
available antibody molecules by the large amount of antigen
present (Figure S2). We found that this problem can be over-
come by reducing the size of the sample through trimming, by
performing multiple rounds of antibody labeling at the regular
concentration (although that extends the time needed for
labeling), or by increasing antibody concentration (although
that increases expense).
Finally, as mentioned, for antibodies compatible with meth-
anol pretreatment, we recommend using the bleaching step
to minimize background autofluorescence and to improve
diffusion. Antibodies incompatible with methanol pretreatment
worked well within our time frame on embryos and small adult
tissues (e.g., a dissected cerebellum or 1 mm sections), but
their diffusion was slower in large samples (e.g., whole adult
brain).
Application to Different Tissues
We showed that iDISCO is useful across many organs, including
kidney, muscle, stomach, and the vasculature. However,
whether it is advantageous to use the protocol will depend on
the application. Many tissues have highly repetitive structures
that can already be well documented in sections. Tissue-specific
protocols that add steps to preserve integrity of fragile tissues
during collection and preparation have been developed, e.g.,
to study lung tissue (Scott et al., 2014) and adult skin (Li et al.,
2011); some of these are likely compatible with iDISCO, but
this needs to be tested. Similarly, bone can be immunolabeled
in sections only after decalcification, but it is not yet known if
that is compatible with iDISCO. Finally, during iDISCO tissues
shrink slightly but consistently because of dehydration, so that
absolute distance or volume measurements (to compare to live
conditions) will require some kind of correction. However, tissue
shrinkage does not change projection or connectivity patterns or
relative distances, allowing detailed comparisons across
different samples all treated by iDISCO.
Microscopy
It is important to choose the appropriate imaging setup. Scan-
ning microscopes (confocal or two-photon) can achieve the
best resolution throughout the whole imaging plane. However,
the slow scanning speeds make them impractical for imaging
large fields of view (Figure S3). Larger fields of view can be
acquired by tiling, but lens distortions (pincushion or barrel dis-
tortions), light fall-off, and potential micromovements of the
sample inside the chamber make it difficult to obtain good
data sets. Light-sheet microscopy has more recently emerged
as a good alternative to image large samples. The advantages
of light-sheet microscopy over point-scanning microscopy are908 Cell 159, 896–910, November 6, 2014 ª2014 Elsevier Inc.reduced sample bleaching, high acquisition speed, large fields
of view, and high dynamic range (Tomer et al., 2014). Its resolu-
tion can be more limited, but for many applications it provides
a superior option, in particular for imaging large numbers of
samples.
Data Processing
Volume imaging generates very large data sets, which can be
challenging to manage. Modern light-sheet microscopes equip-
ped with 5 megapixel sCMOS cameras produce image stacks of
20 Gb for a scan spanning the entire working distance of the
objective (6 mm). Most desktop computers are not able to
open such data sets in RAM memory. However, one can conve-
niently open the stacks as ‘‘virtual stacks.’’ It is possible in this
mode to perform maximum projections, or downsample the im-
ages to a more manageable size to perform 3D projections
directly on ImageJ. However, more complex operations such
as object tracing, automated counting and animated fly-overs
are better done on proprietary software such as Biplane’s Imaris,
and require a powerful workstation.
Implementation and Expense
iDISCO compares favorably with all other protocols in terms of
ease of implementation. It is also inexpensive for sample prepa-
ration, clearing, andmounting for volume imaging.We do recom-
mend use of a light-sheet microscope for fast volume imaging
of large samples and of a high-end image workstation for pro-
cessing large data sets, but the associated costs are similar for
all volume imaging protocols.
In conclusion, we believe that iDISCO provides a versatile and
reliable way to perform immunolabeling followed by volume im-
aging for a wide range of applications. Indeed, although prelim-
inary tests are required to assess the best imaging parameters,
antibody concentrations and incubation times, once those
have been determined it becomes possible to use our workflow
for large-scale screens.
EXPERIMENTAL PROCEDURES
Mice
All surgical and behavioral procedures in mice were performed in compliance
with protocols approved by the Institutional Animal Care and Use Committee
(IACUC) of the Rockefeller University. The Ai14 line (Rosa26lox-stop-lox-dtTomato),
Thy1-GFPM, ChAT-cre, Caspase 3, and Bax mutant lines were obtained from
the Jackson Laboratory. The Netrin-1 gene-trap line was previously described
(Serafini et al., 1996).
Sample Collection
The day of vaginal plug is defined as E0.5. Embryos were collected in ice-cold
Leibovitz’s L-15. Adult mice were heavily anesthetized with an overdose of
isoflurane and fixed with an intracardiac perfusion of 4% PFA in PBS. All har-
vested samples were postfixed overnight at 4C in 4% PFA in PBS, and then
again 1 hr at room temperature the next day.
Sample Pretreatment with Methanol
Fixed samples were washed in PBS for 1 hr twice, then in 50% methanol (in
PBS) for 1 hr, 80% methanol for 1 hr, 100% methanol for 1 hr twice. Samples
were then bleached with 5%H2O2 in 20%DMSO/methanol (1 vol 30%H2O2/1
vol DMSO/4 vol methanol, ice cold) at 4C overnight. After bleaching, samples
were washed in methanol for 1 hr twice, then in 20% DMSO/methanol for 1 hr
twice, then in 80%methanol for 1 hr, 50%methanol for 1 hr, PBS for 1 hr twice,
and finally in PBS/0.2% Triton X-100 for 1 hr twice before further staining
procedures.
Sample Pretreatment without Methanol
Fixed samples were washed in PBS for 1 hr twice, then in PBS/0.2% Triton
X-100 for 1 hr twice, then incubated in PBS/0.2% Triton X-100/20%
DMSO at 37C overnight, then in PBS/0.1% Tween-20/0.1% Triton X-
100/0.1% deoxycholate/0.1% NP40/20% DMSO at 37C overnight, then
washed in PBS/0.2% Triton X-100 for 1 hr twice before further staining
procedures.
EdU Labeling Protocol
EdU was suspended in 0.9% NaCl and injected at 50 mg/kg intraperitoneally
(i.p.) 1 hr prior to tissue harvest.We used the click reaction-based EdU imaging
kit (Invitrogen; MP10637) to label actively proliferating cells in embryos and
adult organs.
Immunolabeling Protocol
Pretreated samples were incubated in PBS/0.2% Triton X-100/20% DMSO/
0.3 M glycine at 37C overnight, then blocked in PBS/0.2% Triton X-100/
10%DMSO/6%Donkey Serum at 37C for indicated time (Table S2). Samples
were washed in PBS/0.2% Tween-20 with 10 mg/ml heparin (PTwH) for 1 hr
twice, then incubated in primary antibody dilutions in PTwH/5% DMSO/3%
Donkey Serum at 37C for indicated time. Samples were then washed in
PTwH for 1 day, then incubated in secondary antibody dilutions in PTwH/
3% Donkey Serum at 37C for indicated time. Samples were finally washed
in PTwH for 2 days before clearing and imaging. For nuclear labeling, immuno-
labeled samples were incubated with TO-PRO-3 (1:5,000 in PTwH) for 1 hr,
then washed in PTwH.
Tissue Clearing and Precautions with Solvents
Immunolabeled or traced tissues were cleared with a simplified version of
3DISCO (Ertu¨rk et al., 2012a). Samples were incubated overnight in 10 ml of
50% v/v tetrahydrofuran/H2O (THF) (Sigma 186562-12X100ML). Samples
were then incubated for 1 hr in 10 ml of 80% THF/H2O and twice 1 hr in
100%THF and then in dichloromethane (DCM) (Sigma 270997-12X100ML) un-
til they sank at the bottom of the vial. Finally, samples were incubated in 18 ml
of dibenzyl ether (DBE) (Sigma 108014-1KG) until clear (2 hr) and then stored
in DBE at room temperature. Organic solvents should be handled under a
chemical hood and disposed of following local health and safety regulations.
DBE, which is used for storage and imaging, is a skin irritant exhibiting toxicity
class II (moderate toxicity) according to the material safety data sheets
(MSDSs) and should be handled with care, including wearing gloves, but
with those precautions can be used on an open bench for slide mounting
and for microscopy.
Imaging
Large samples (embryos from E12.5 and dissected organs) were imaged on
a light-sheet microscope (Ultramicroscope II, LaVision Biotec) equipped with
a sCMOS camera (Andor Neo) and a 23/0.5 objective lens equipped with a
6 mm working distance dipping cap. Samples presented in Figure 2C (E16
Forearm), Figure 3B (cortical neurons), Figure 6B (DRGs and trigeminal nerve),
and Figure 7A (dLGN) were imaged on a 2 photonmicroscope (Olympus) with a
103/0.6, 3 mm working distance or a 253/1.05, 2 mm working distance
objective.
Image Processing and Analysis
Because of the very high dynamic range (15 bit) of the images generated on
the light sheet microscope, for display purposes a gamma correction was
applied on data sets obtained from the light-sheet microscope. Maximum pro-
jections were performed using ImageJ (NIH, http://imagej.nih.gov/ij/). Simple
3D projections were performed with VAA3D (Peng et al., 2010) on desktop-
class computers. Imaris (Bitplane, http://www.bitplane.com/imaris/imaris)
was used for 3D manipulations. cCasp3+ cells were counted from maximum
projections encompassing the entire DRGs and the data where plotted with
Prism (Graphpad, http://www.graphpad.com/scientific-software/prism/).Cholera Toxin Beta Eye Injection
Animals were anesthetized with isoflurane. One microliter of 1% cholera toxin
in PBS conjugated to either Alexa Fluor 594 or Alexa Fluor 488 was injected
into the retina with a fine Hamilton Syringe. Mice were analyzed after 24 hr.
After fixation by cardiac perfusion with 4% paraformaldehyde in PBS,
brains were dissected and postfixed in 4% PFA in PBS overnight at 4C.
Brains were then washed in PBS for 1 hr at room temperature, cleared, and
imaged.
Nerve Injuries
For sciatic nerve crush, the mice were anesthetized, an incision was made be-
tween the knee and the hip joint, and the gluteal muscles were separated. The
sciatic nerve was crushed for 30 s with a pair of fine forceps. Twenty-four hours
after nerve injury the mice were perfused, and L4 and L5 DRGs were dissected
and postfixed overnight at 4C. For optic nerve crush, intravitreal injection of
AAV2 was performed on 2- to 4-month-old animals. For sparse labeling, 2 3
103 transduction units of AAV2 were delivered. Three weeks after viral injec-
tion, mice were anesthetized, and topical antibiotic ointment was applied to
the eyes before optic nerve crush surgery. An incision was made on the supe-
rior conjunctiva of the left eye, and the optic nerve was exposed by a pair of
blunt forceps. The crush injury was performed for 10 s using a pair of fine-tip
forceps at 1 mm distal from the eyeball.
Heat Stimulation for c-fos Expression Induction
One-month-old C57Bl6 mice were anesthetized with isoflurane and their left
paws were dipped ten times for 5 s each in a water bath at 52C (10 s intervals
between each stimulation). Mice were returned to their cage for 2 hr then anes-
thetized with an overdose of isoflurane and perfused with 4% PFA in PBS.
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